Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

  1. Client, organization or corporation number: 15042
Share this search Create an alert
Start over
Modify criteria

Refine registrations results by

Status Type Subject matter Government institutions

Refine monthly communication reports results by

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (58)
Results: 1-50 | Export
  1. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Gaby Bourbara, President
    Registration: 58 of 58 (2024-04-30 to present)
    Posted: 2024-05-10
    Subject matter details: 13
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 13
  2. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Gaby Bourbara, President
    Registration: 57 of 58 (2024-03-01 to 2024-04-30)
    Posted: 2024-03-05
    Subject matter details: 14
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 13
  3. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Kiersten Combs, President
    Registration: 56 of 58 (2023-07-06 to 2024-03-01)
    Posted: 2023-07-10
    Subject matter details: 14
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 14
  4. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Kiersten Combs, President
    Registration: 55 of 58 (2023-05-12 to 2023-07-06)
    Posted: 2023-05-12
    Subject matter details: 14
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 13
  5. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Kiersten Combs, President
    Registration: 54 of 58 (2023-02-24 to 2023-05-12)
    Posted: 2023-02-27
    Subject matter details: 14
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 14
  6. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Kiersten Combs, President
    Registration: 53 of 58 (2023-02-08 to 2023-02-24)
    Posted: 2023-02-08
    Subject matter details: 14
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 12
  7. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Kiersten Combs, President
    Registration: 52 of 58 (2022-10-12 to 2023-02-08)
    Posted: 2022-10-12
    Subject matter details: 14
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 11
  8. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Kiersten Combs, President
    Registration: 51 of 58 (2022-09-06 to 2022-10-12)
    Posted: 2022-09-12
    Subject matter details: 14
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 11
  9. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Kiersten Combs, President
    Registration: 50 of 58 (2022-07-13 to 2022-09-06)
    Posted: 2022-07-13
    Subject matter details: 14
    Government institutions: 29
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 11
  10. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Kiersten Combs, President
    Registration: 49 of 58 (2022-01-13 to 2022-07-13)
    Posted: 2022-01-13
    Subject matter details: 14
    Government institutions: 29
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 11
  11. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Kiersten Combs, President
    Registration: 48 of 58 (2021-12-15 to 2022-01-13)
    Posted: 2021-12-15
    Subject matter details: 14
    Government institutions: 29
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9
  12. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Kiersten Combs, President
    Registration: 47 of 58 (2021-10-28 to 2021-12-15)
    Posted: 2021-10-29
    Subject matter details: 14
    Government institutions: 29
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9
  13. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Kiersten Combs, President
    Registration: 45 of 58 (2021-09-01 to 2021-09-01)
    Posted: 2021-09-02
    Subject matter details: 14
    Government institutions: 29
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9
  14. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Kiersten Combs, President
    Registration: 46 of 58 (2021-09-01 to 2021-10-28)
    Posted: 2021-09-28
    Subject matter details: 14
    Government institutions: 29
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9
  15. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Jane Chung, President
    Registration: 44 of 58 (2021-03-01 to 2021-09-01)
    Posted: 2021-03-30
    Subject matter details: 14
    Government institutions: 29
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9
  16. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Jane Chung, President
    Registration: 43 of 58 (2021-02-05 to 2021-03-01)
    Posted: 2021-02-24
    Subject matter details: 12
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9
  17. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Jane Chung, President
    Registration: 42 of 58 (2020-12-07 to 2021-02-05)
    Posted: 2020-12-08
    Subject matter details: 12
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  18. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Jane Chung, President
    Registration: 41 of 58 (2020-10-28 to 2020-12-07)
    Posted: 2020-11-13
    Subject matter details: 12
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  19. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Jane Chung, President
    Registration: 40 of 58 (2020-04-27 to 2020-10-28)
    Posted: 2020-04-28
    Subject matter details: 12
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  20. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Jane Chung, President
    Registration: 39 of 58 (2019-11-01 to 2020-04-27)
    Posted: 2019-11-18
    Subject matter details: 12
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  21. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Daniel Smedley, VP, Finance & IT, Interim President
    Registration: 38 of 58 (2019-08-01 to 2019-11-01)
    Posted: 2019-08-29
    Subject matter details: 12
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 8
  22. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Jamie Freedman, President and Chief Executive Officer
    Registration: 36 of 58 (2019-06-26 to 2019-06-26)
    Posted: 2019-06-26
    Subject matter details: 12
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9
  23. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Jamie Freedman, President and Chief Executive Officer
    Registration: 37 of 58 (2019-06-26 to 2019-08-01)
    Posted: 2019-06-27
    Subject matter details: 12
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 8
  24. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Jamie Freedman, President and Chief Executive Officer
    Registration: 35 of 58 (2019-02-04 to 2019-06-26)
    Posted: 2019-02-07
    Subject matter details: 12
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 8
  25. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Jamie Freedman, President and Chief Executive Officer
    Registration: 34 of 58 (2017-12-19 to 2019-02-04)
    Posted: 2017-12-19
    Subject matter details: 12
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 8
  26. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Jamie Freedman, President and Chief Executive Officer
    Registration: 33 of 58 (2017-11-28 to 2017-12-19)
    Posted: 2017-11-30
    Subject matter details: 12
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  27. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Ed Dybka, President and Chief Executive Officer
    Registration: 32 of 58 (2017-08-10 to 2017-11-28)
    Posted: 2017-08-11
    Subject matter details: 12
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  28. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Ed Dybka, President and Chief Executive Officer
    Registration: 31 of 58 (2017-05-15 to 2017-08-10)
    Posted: 2017-05-18
    Subject matter details: 12
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  29. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Ed Dybka, President and Chief Executive Officer
    Registration: 30 of 58 (2017-01-30 to 2017-05-15)
    Posted: 2017-02-01
    Subject matter details: 12
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  30. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Ed Dybka, President and Chief Executive Officer
    Registration: 29 of 58 (2016-10-03 to 2017-01-30)
    Posted: 2016-10-03
    Subject matter details: 12
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  31. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Ed Dybka, President and Chief Executive Officer
    Registration: 28 of 58 (2016-08-26 to 2016-10-03)
    Posted: 2016-08-30
    Subject matter details: 12
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  32. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Ed Dybka, President and Chief Executive Officer
    Registration: 27 of 58 (2016-07-21 to 2016-08-26)
    Posted: 2016-07-21
    Subject matter details: 12
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  33. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Ed Dybka, President and Chief Executive Officer
    Registration: 26 of 58 (2015-12-21 to 2016-07-21)
    Posted: 2015-12-22
    Subject matter details: 12
    Government institutions: 27
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 7
  34. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Ed Dybka, President and Chief Executive Officer
    Registration: 25 of 58 (2015-08-21 to 2015-12-21)
    Posted: 2015-08-24
    Subject matter details: 12
    Government institutions: 27
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 7
  35. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Ed Dybka, President and Chief Executive Officer
    Registration: 24 of 58 (2015-04-22 to 2015-08-21)
    Posted: 2015-04-23
    Subject matter details: 12
    Government institutions: 27
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 7
  36. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Ed Dybka, President and Chief Executive Officer
    Registration: 23 of 58 (2015-01-02 to 2015-04-22)
    Posted: 2015-01-13
    Subject matter details: 12
    Government institutions: 27
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  37. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Elaine Campbell, President and Chief Executive Officer
    Registration: 22 of 58 (2014-11-18 to 2015-01-02)
    Posted: 2014-11-18
    Subject matter details: 12
    Government institutions: 27
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  38. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Elaine Campbell, President and Chief Executive Officer
    Registration: 21 of 58 (2014-07-08 to 2014-11-18)
    Posted: 2014-07-08
    Subject matter details: 11
    Government institutions: 27
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 5
  39. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Elaine Campbell, President and Chief Executive Officer
    Registration: 20 of 58 (2014-03-14 to 2014-07-08)
    Posted: 2014-03-17
    Subject matter details: 11
    Government institutions: 27
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 5
  40. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Elaine Campbell, President and Chief Executive Officer
    Registration: 19 of 58 (2014-01-22 to 2014-03-14)
    Posted: 2014-01-22
    Subject matter details: 11
    Government institutions: 26
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 5
  41. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Elaine Campbell, President and Chief Executive Officer
    Registration: 18 of 58 (2014-01-07 to 2014-01-22)
    Posted: 2014-01-09
    Subject matter details: 11
    Government institutions: 26
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  42. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Elaine Campbell, President and Chief Executive Officer
    Registration: 17 of 58 (2013-11-20 to 2014-01-07)
    Posted: 2013-11-20
    Subject matter details: 11
    Government institutions: 26
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  43. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Elaine Campbell, President and Chief Executive Officer
    Registration: 16 of 58 (2013-02-28 to 2013-11-20)
    Posted: 2013-02-28
    Subject matter details: 11
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  44. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Elaine Campbell, President and Chief Executive Officer
    Registration: 15 of 58 (2012-03-15 to 2013-02-28)
    Posted: 2012-03-19
    Subject matter details: 11
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  45. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Elaine Campbell, President and Chief Executive Officer
    Registration: 14 of 58 (2012-01-09 to 2012-03-15)
    Posted: 2012-02-10
    Subject matter details: 11
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  46. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Marion McCourt, President and Chief Executive Officer
    Registration: 13 of 58 (2011-08-25 to 2012-01-09)
    Posted: 2011-09-02
    Subject matter details: 11
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  47. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Marion McCourt, President and Chief Executive Officer
    Registration: 12 of 58 (2011-06-01 to 2011-08-25)
    Posted: 2011-07-15
    Subject matter details: 10
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  48. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Marion McCourt, President and Chief Executive Officer
    Registration: 11 of 58 (2011-05-13 to 2011-06-01)
    Posted: 2011-05-17
    Subject matter details: 10
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  49. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Marion McCourt, President and Chief Executive Officer
    Registration: 10 of 58 (2010-11-12 to 2011-05-13)
    Posted: 2010-11-22
    Subject matter details: 10
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  50. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Responsible officer: Marion McCourt, President and Chief Executive Officer
    Registration: 9 of 58 (2010-05-13 to 2010-11-12)
    Posted: 2010-08-15
    Subject matter details: 10
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
Date Modified: